Eczema Awareness Month
Eczema Awareness Month
Around 16.5 million adults and 8 million children in the U.S. have eczema.1,2 Nearly 6.6 million adults say they have moderate-to-severe symptoms.3 Atopic dermatitis (AD) is the most common form of eczema.
October Is National Eczema Awareness Month
During October, join the Asthma and Allergy Foundation of America (AAFA) as we raise awareness of eczema. AAFA invites you to use our resources and tools to teach others what it’s like to live with eczema.
How to share images:
Click or tap on an image. Save it to your computer or mobile device. For desktop computers, right-click and “save as.” Then share the image with your friends and family via social media. Be sure to tag us!
Be sure to follow us on Facebook, Instagram, YouTube, and TikTok!
Change Your Profile Pictures
Share Our Awareness Images
We have many shareable images throughout our website. Here are some of our favorites about eczema:
Watch and Share Our Awareness Videos
We hear many questions about how eczema is related to food allergy, so we asked the expert.
Watch Atopic Dermatitis and Eczema Educational Webinars
AAFA offers a variety of free webinars for people with atopic dermatitis and eczema, and their caregivers.
Caring for the Littles with Eczema: Taking Care of Yourself and Your Child
Watch now on demand – no registration required! Learn more about managing eczema in young children and self-care strategies for caregivers in this educational webinar hosted by AAFA and Medlive. Topics discussed during this 4-part video series include:
- Eczema treatment options for babies and young children
- How to look after your mental health while caring for a child with eczema
- Understanding the risks of developing food allergies or asthma when your child has eczema
- Stories from a doctor and caregiver about treating a child’s eczema and making decisions together
It Isn’t Just Skin: The Ins and Outs of Moderate-to-Severe Atopic Dermatitis
Learn more about managing moderate-to-severe atopic dermatitis in this educational webinar hosted by AAFA and Medlive. Topics discussed during this webinar include:
- Causes of atopic dermatitis
- Symptoms and triggers of atopic dermatitis
- Treatment options
- Importance of clinical trials, particularly with diverse populations
Taking Charge of My Eczema
It is important to understand the treatment options for eczema and how to work with your doctor to understand the best treatment for you. Watch this webinar, hosted by AAFA and Medlive, that covers the following topics:
- How eczema affects the skin and other parts of the body
- Talking with your doctor about your eczema and treatment
- Making decisions with your doctor about treatment to reach your goals
Watch CME Programs on Atopic Dermatitis
View our programs on atopic dermatitis. You can earn an AMA PRA Category 1 Credit™, as noted.
Atopic Dermatitis and Its Comorbid Conditions: How Knowing About Them Will Help Guide Your Treatment Decisions
Topics covered during this program include:
- Current evidence for currently approved agents for the treatment of moderate-to-severe atopic dermatitis (AD)
- How the presence of comorbidities can influence the treatment of moderate-to-severe AD
- How to help patients reach long-term control of their disease
Earn AMA PRA Category 1 Credit™ through Oct. 20, 2024. Watch on demand.
Caring for the Littles with Atopic Dermatitis: Clinician-Caregiver Collaboration
Topics covered during this program include:
- Guideline recommendations for the management of moderate-to-severe atopic dermatitis (AD) in infants and young children
- Efficacy and safety data from recent studies on treatments
- The effects of newer treatments for AD on patient outcomes
Earn AMA PRA Category 1 Credit™ through August 21, 2025. Watch on demand.
Disparity and Equity in Moderate-to-Severe AD Care: Enhancing Access to Multidisciplinary Care for Patients from Diverse Populations
Topics covered during this program include:
- The impacts that age, race, and ethnicity have on atopic dermatitis (AD)
- Management of moderate-to-severe atopic dermatitis
- The unique challenges that people from diverse racial and ethnic group face when attempting to access care
Please note AMA PRA Category 1 Credit™ is no longer available.
Endophenotypes, Evidence, and Long-Term Outcomes in Moderate-to-Severe Atopic Dermatitis Management: A Decision Library
Topics covered during this program include:
- Alignment of therapeutic decisions to clinical endophenotypes in patients of different age groups and races
- Evidence-based treatment recommendations to achieve long-term disease control
- Strategies to encourage shared-decision-making with patients
Please note AMA PRA Category 1 Credit™ is no longer available. There are four modules in this program.
Module 1
Module 2
Module 3
Module 4
Closed Accordion
References
- Eczema in Skin of Color: What You Need to Know. (2018, February 16). National Eczema Association. https://nationaleczema.org/blog/eczema-in-skin-of-color/
- FLG Gene: MedlinePlus Genetics. (n.d.). MedlinePlus. Retrieved September 11, 2024, from https://medlineplus.gov/genetics/gene/flg/#conditions
- Chiesa Fuxench ZC, Block JK, Boguniewicz M, Boyle J, Fonacier L, Gelfand JM, Grayson MH, Margolis DJ, Mitchell L, Silverberg JI, Schwartz L, Simpson EL, Ong PY. Atopic Dermatitis in America Study: A Cross-Sectional Study Examining the Prevalence and Disease Burden of Atopic Dermatitis in the US Adult Population. J Invest Dermatol. 2019 Mar;139(3):583-590. doi: 1016/j.jid.2018.08.028. Epub 2018 Oct 30. PMID: 30389491.
